Taclonex Scalp Topical Suspension.(New Approved)Mechcatie, Elizabeth
原文链接: http://www.cnbc.com/id/49570695/LEO_Pharma_Inc_Receives_FDA_Approval_for_Taclonex_R_calcipotriene_and_betamethasone_dipropionate_Topical_Suspension_0_005_0_064_for_Body_Plaque_Psoriasis_New_first_line_single_treatment_for_both_scalp_and_body_plaque_psoriasis_indicated_for_up_to_8_week...
Adults may use the suspension form of this medicine on the skin or the scalp. The liquid may be used only on the scalp in children who are at least 12 years old. Patients 12 to 17 years should not use more than 60 grams of the suspension per week and patients 18 years and older ...
(maximum recommended duration of treatment) and also after 8 weeks of once daily application of Taclonex® Ointment on the body in combination with Taclonex Scalp® Topical Suspension on the scalp. Both calcipotriene and betamethasone dipropionate were below the lower limit of quantification in ...
calcipotriene and betamethasone dipropionate and their major metabolites were measured after 4 weeks (maximum recommended duration of treatment) and also after 8 weeks of once daily application of Taclonex® Ointment on the body in combination with Taclonex Scalp® Topical Suspension on the scalp....
基本信息 序号 47-4 药品名称 卡泊三醇倍他米松混悬液 商品名 Taclonex 英文名称 Calcipotriol and Betamethasone Dipropionate Suspension 规格 卡泊三醇50μg/g,倍他米松0.5mg/g 剂型 混悬剂 持证商 LEO Pharma A/S 备注1 未进口原研产品 备注2
Pharmaceutical active ingredients: Betamethasone Dipropionate Calcipotriol Hydrate Available forms, composition and doses of Taclonex Scalp: Suspension; Topical; Betamethasone Dipropionate 0.064%; Calcipotriol Hydrate 0.005% Medical categories: Human: Anti-inflammatory agents ...
DaivobetDovobetXamiolEnstilarPsorcutan BetaTaclonex TokenDyvon PlusTaclonex (Topical application)Taclonex ScalpCalcipoheal CortTaclonex (topical)Psori-BetTaclonex Scalp (topical)Taclonex Topical SuspensionCalcipotriol + Betamethasone TevaTaclonex Scalp (Topical application)Taclonex suspensionDaivobetoiTaclonex ointment...
Taclonex Gains IndicationThe article reports on the approval of Taclonex Topical Suspension from LEO Pharma Inc. for body plaque psoriasis treatment in patients 18 years old and above.Monthly Prescribing Reference